跳至主要内容
临床试验/NCT01945892
NCT01945892已完成不适用

Ozurdex as an Treatment Option for Macula Edema Due to Irvine Gass Syndrome

Ludwig-Maximilians - University of Munich1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
23
试验地点
1
主要终点
Visual acuity

研究概览

简要总结

To analyze macula edema formation after cataract surgery called Irvine-Gass-Syndrome.

详细描述

20 to 25 patients suffering from Irvine Gass Syndrom should be monitored for at least six months, controlled monthly. In all cases best corrected visual acuity, Spectralis-OCT (volume thickness scan), fundus photography (Optomap), intraocular pressure, slitlamp assessment and indirect ophthalmoscopy should be performed on every visit. Fluorescein angiography should be performed at baseline and after 3 and 6 months.

Inclusion criteria:

Patients older than 18 years who develop macula edema secondary to cataract surgery.

  • Consent agreement - Patients should be informed that it is possible to get an active medication (Ozurdex implant) as an "on label" indication from the health insurance company if the diagnosis is accepted as an intraocular inflammation form of "Uveitis posterior".

Exclusion criteria:

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 years who develop macula edema secondary to cataract surgery

排除标准

  • Visual acuity worse than 20/400, known history of glaucoma and steroid response, any macular disease interfering with visual acuity (DME, AMD, etc.), history of vitrectomy, use of systemic, periocular, or intraocular corticosteroids within 30 days.

研究组 & 干预措施

Irvine Gass Syndrome

Patients older than 18 years who develop macula edema secondary to cataract surgery.

Group may receive intravitreal Ozurdex medication in case of persistent macular edema.

干预措施: Ozurdex (Drug)

结局指标

主要结局

Visual acuity

时间窗: 12 months

Best corrected visual acuity and visual acuity gain after 6 and 12 months.

次要结局

  • Retinal Thickness(12 months)
  • Intraocular pressure(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wolfgang Mayer

Dr.

Ludwig-Maximilians - University of Munich

研究点 (1)

Loading locations...

相似试验